Liminatus Pharma, Inc. (LIMN) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2023: -$15.79M2024: -$19.34M2025: -$9.81M-$9.81M
2023Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$9.81M+49.3%
2024-$19.34M-22.5%
2023-$15.79M